Come up with a name for your new list and we'll add to it:
Advanced Cell Diagnostics raised a round of funding on September 21, 2009. Investors include
Morningside Group (晨兴集团).
Advanced Cell Diagnostics (ACD) is a provider in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The company's products and ser…